Neuro-Ophthalmologic Features and Outcomes of Thalamic Infarction: A Single-Institutional 10-Year Experience

Background: Neuro-ophthalmologic deficit after thalamic infarction has been of great concern to ophthalmologists because of its debilitating impacts on patients' daily living. We aimed to describe the visual and oculomotor features of thalamic infarction and to delineate clinical outcomes and prognostic factors of the oculomotor deficits from an ophthalmologic point of view.

Original Contribution Section Editors: Clare Fraser, MD Susan Mollan, MD Neuro-Ophthalmologic Features and Outcomes of Thalamic Infarction: A Single-Institutional 10-Year Experience Yeji Moon, MD, Kyu Sang Eah, MD, Eun-Jae Lee, MD, PhD, Dong-Wha Kang, MD, PhD, Sun Uck Kwon, MD, PhD, Jong Sung Kim, MD, PhD, Hyun Taek Lim, MD, PhD Downloaded from http://journals.lww.com/jneuro-ophthalmology by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= on 05/04/2022 Background: Neuro-ophthalmologic deficit after thalamic infarction has been of great concern to ophthalmologists because of its debilitating impacts on patients’ daily living. We aimed to describe the visual and oculomotor features of thalamic infarction and to delineate clinical outcomes and prognostic factors of the oculomotor deficits from an ophthalmologic point of view. Methods: Clinical and neuroimaging data of all participants were retrospectively reviewed. Among the 12,755 patients with first-ever ischemic stroke, who were registered in our Stroke Data Bank between January 2009 and December 2018, 342 were found to have acute thalamic infarcts on MRI, from whom we identified the patients exhibiting neuroophthalmologic manifestations including visual, oculomotor, pupillary, and eyelid anomalies. Results: Forty (11.7%) of the 342 patients with thalamic infarction demonstrated neuro-ophthalmologic manifestations, consisting of vertical gaze palsy (n = 19), skew deviation with an invariable hypotropia of the contralesional eye (n = 18), third nerve palsy (n = 11), pseudoabducens palsy (n = 9), visual field defects (n = 7), and other anomalies such as isolated ptosis and miosis (n = 7). Paramedian infarct was the most predominant lesion of neuroophthalmologic significance, accounting for 84.8% (n = 28) of all patients sharing the oculomotor features. Although most of the patients with oculomotor abnormalities rapidly improved without sequelae, 6 (18.2%) patients showed permanent oculomotor deficits. Common clinical features of patients with permanent oculomotor deficits included the following: no improvement within 3 months, combined upgaze and downgaze palsy, and the involvement of the paramedian tegmentum of the rostral midbrain. Conclusions: Thalamic infarction, especially in paramedian territory, can cause a wide variety of neuro-ophthalmologic Departments of Ophthalmology (YM, KSE, HTL) and Neurology (E-JL, D-WK, SUK, JSK), Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. The authors report no conflicts of interest. Address correspondence to Hyun Taek Lim, MD, PhD, Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-Ro 43 Gil, Songpa-Gu, Seoul 05505, South Korea; E-mail: [e-mail] Moon et al: J Neuro-Ophthalmol 2021; 41: 29-36 manifestations, including vertical gaze palsy, skew deviation, and third nerve palsy. Although most oculomotor abnormalities resolve spontaneously within a few months, some may persist for years when the deficits remain unimproved for more than 3 months after stroke. Journal of Neuro-Ophthalmology 2021;41:29–36 doi: 10.1097/WNO.0000000000000864 © 2019 by North American Neuro-Ophthalmology Society T halamic infarction accounts for approximately 4% of all cerebral infarctions and 11% of all vertebrobasilar infarctions. It gives rise to a wide range of neurologic syndromes depending on the arterial territories and associated nuclei. In addition to classical sensorimotor and amnestic syndromes, thalamic infarction can lead to the development of numerous visual and eye movement dysfunctions, either in isolation or in combination with infarction involving other structures (1–8). Because of its immediate proximity to the rostral midbrain and thalamomesencephalic junction, the critical area for supranuclear premotor control of vertical eye movements, thalamic infarction can produce various eye movement dysfunction. However, apart from the effects caused by the anatomical vicinity to the midbrain, the thalamus alone can cause several oculomotor deficits. Another clinical characteristic of patients with thalamic infarction is visual field defects mainly due to the involvement of the lateral geniculate nucleus (4,9–12). Visual and oculomotor deficits after thalamic infarction have been a subject of great concern because of the resultant disease burden and serious disability affecting everyday activities. However, great uncertainty is associated with not only the underlying mechanisms of the oculomotor deficits but also its potential future clinical courses and the best method of management. Although several studies have been conducted to investigate clinical features of thalamic infarction, only a few have addressed its neuro-ophthalmologic 29 Copyright © North American Neuro-Ophthalmology Society. Unauthorized reproduction of this article is prohibited. Original Contribution features in detail, even in case series studies of thalamic infarction with small samples (13–15). The purpose of this study was to describe the visual and oculomotor features of patients who presented to our institution with thalamic infarction over a period of 10 years and to delineate the clinical outcome and prognostic factors of the ocular motility deficits from an ophthalmologic point of view. METHODS We retrospectively reviewed the clinical and neuroimaging data of all the patients registered in our Stroke Data Bank between January 2009 and December 2018. Among the 12,755 registered patients, 342 (2.68%) were identified to have thalamic infarction: 282 with isolated thalamic lesions and 60 with additional extrathalamic lesions. We finally included the patients with thalamic infarction who had neuro-ophthalmologic features including visual, oculomotor, pupillary, and eyelid abnormalities. MRI including diffusion-weighted imaging and MRA was performed in all patients with thalamic infarction within 24 hours of the onset of symptoms, and a neuroradiologist independently read the images. The topography of thalamic infarction was categorized into 4 groups depending on their arterial supply: (1) paramedian infarction in the territory of the paramedian artery, (2) polar infarction in the territory of the polar artery, (3) inferolateral infarction in the territory of the inferolateral artery, previously called thalamogeniculate artery, and (4) posterior choroidal infarction in the territory of the posterior choroidal artery (1,2,4,7). The etiology of infarction was assessed according to the Trial of Org 10172 in Acute Stroke Treatment (TOAST) classification criteria, combining risk profile of the patients with the results of the following tests: complete blood cell count, coagulation laboratory test, 12-lead electrocardiography, transthoracic or transesophageal echocardiography, duplex sonography of the carotid arteries, MRI, and MRA. The causes of thalamic infarction were classified into 5 subgroups: (1) large-artery atherosclerosis, (2) cardioembolism, (3) small-vessel occlusion, (4) stroke of other determined etiology, and (5) stroke of undetermined etiology (16). At the initial visit, a neurologist performed a thorough neurological examination. Visual field tests were performed by using a Humphrey field analyzer (Swedish Interactive Threshold Algorithm [SITA] 30-2; Carl Zeiss Meditec, Dublin, CA) or a by confrontation method depending on the patient’s co-operability. A comprehensive evaluation of external and internal oculomotor functions, including ocular alignment, duction and version, pupillary and eyelid functions, and involuntary eye movement, was performed. A detailed analysis of patient data on neuro-ophthalmologic features and outcomes, including both visual and oculomotor aspects, was performed. 30 This study adhered to the tenets of the Declaration of Helsinki, and the institutional review board of the Asan Medical Center approved the protocol. RESULTS Among the 342 patients with thalamic infarction, 40 (11.7%) patients developed neuro-ophthalmologic manifestations. The mean age was 59.2 ± 14.4 years (range, 21.4–80.4 years), and 16 men were included. Most of the patients had other combined infarcts, and only 8 (20.0%) patients showed isolated thalamic infarcts. The demographic data and distribution of lesions are summarized in Table 1. Among the 40 patients, 11 patients (10 patients with paramedian infarctions and 1 patient with polar infarction) were notified to have consciousness changes, and 2 patients (1 patient with paramedian infarction and 1 patient with polar infarction) showed memory deficits. Among the 342 patients with thalamic infarction, 54 patients with paramedian infarction were identified; among them, 28 (51.9%) were discovered to have oculomotor abnormalities. The most common oculomotor abnormality was vertical gaze palsy, followed by skew deviation with an invariable hypotropia of the contralesional eye. Ipsilateral ptosis without third cranial nerve palsy was found in 3 patients, one of whom had associated ipsilateral miosis and the other 2 had normal pupillary function. Among the 55 patients with polar infarction, 2 (3.6%) demonstrated ipsilateral ptosis without miosis as a sole neuroophthalmological feature. Among 217 patients with inferolateral infarction, only 5 (2.3%) presented with significant neuro-ophthalmological signs, and among 38 patients with posterior choroidal infarction, 5 (13.2%) had the following neuro-ophthalmologic manifestations: one-and-a-half syndrome in a patient with multiple infarcts in the thalamus, pons, and temporal lobe and visual field defects in 4 patients (Fig. 1 and Table 2). According to the range of infarction on diffusionweighted neuroimaging, we classified our 40 patients into a isolated thalamic infarction group and combined thalamic infarction group. The 8 patients with isolated thalamic infarction (7 with paramedian infarction and 1 with polar infarction) did not fail to show significant neuroophthalmologic signs (Table 3). Oculomotor abnormalities, the most prevalent neuroophthalmologic manifestations of thalamic infarction, resolved rapidly within 3 months of onset in 22 cases (66.7%). However, if the abnormalities did not spontaneously resolve within 3 months, they remained stable for longer than 1 year. Consequently, except for 5 cases who could not confirm the duration of oculomotor abnormalities, 6 (18.2%) of the 33 patients maintained their oculomotor abnormalities far beyond 1 year after onset (average duration: 26 months). Their clinical characteristics are summarized in Table 4. Moon et al: J Neuro-Ophthalmol 2021; 41: 29-36 Copyright © North American Neuro-Ophthalmology Society. Unauthorized reproduction of this article is prohibited. Original Contribution TABLE 1. Demographics, causes of stroke, and distribution of lesions in patients with neuro-ophthalmologic manifestations of thalamic infarction Paramedian Infarction (n = 28) Polar Infarction (n = 2) Inferolateral Infarction (n = 5) Posterior Choroidal Infarction (n = 5) 58.0 ± 14.9 21.4–78.4 9: 19 12 (42.9) 5 (17.9) 6 (21.4) 18 (64.3) 10 5 5 1 1 4 (14.3) 20: 2: 6 21: 7 66.0 ± 6.2 60.6–69.4 1: 1 1 (50.0) 1 (50.0) 0 1 (50.0) 1 0 0 0 0 0 0: 0: 1 2: 0 67.9 ± 11.4 55.0–80.4 4: 1 3 (60.0) 3 (60.0) 2 (40.0) 0 1 (20.0) 3: 1: 1 4: 1 54.7 ± 15.0 33.9–70.8 2: 3 2 (40.0) 0 2 (40.0) 2 (40.0) 1 1 0 0 0 0 2: 0: 3 5: 0 7 (25.0) 14 (50.0) 3 (10.7) 0 4 (14.3) 1 (50.0) 0 1 (50.0) 0 0 5 (100.0) 0 0 0 0 2 (40.0) 2 (40.0) 0 0 1 (20.0) 7 (25.0) 19 (67.9) 5 (17.9) 1 (3.7) 1 (3.7) 1 (3.7) 1 (3.7) 0 0 1 (50.0) 0 0 0 0 0 0 0 1† (33.3) 0 (20.0) (40.0) (60.0) (20.0) (20.0) 0 2 (40.0) 0 0 0 1 (20.0) 3 (60.0) 2 (40.0) 0 0 0 1‡ (50.0) Age (year) Mean ± SD Range Sex (M: F) Hypertension, no. (%) Diabetes mellitus, no. (%) Hypercholesterolemia, no. (%) Cardiac disease, no. (%) Atrial fibrillation* Valve disease* Congenital heart disease Myocardial infarction Other Malignancy Smoking (never: ex-smoker: Yes) Laterality (unilateral: Bilateral) Cause of stroke, no. (%) Large-artery atherosclerosis Cardioembolism Small-vessel occlusion Other determined Undetermined Infarct location, no. (%) Thalamus only Midbrain Cerebellum Occipital lobe Temporal lobe Parietal lobe Frontal lobe Basal ganglia and internal capsule Others 1 2 3 1 1 *Four patients had atrial fibrillation related to cardiac valve disease. † Hypothalamus. ‡ Pons. We investigated the common characteristics shared by these 6 patients with persistent oculomotor deficits. Their one common characteristic was that all were diagnosed to have combined upgaze and downgaze palsy as well as ocular tilt reaction at their initial ophthalmologic evaluation. Among the 7 patients with combined upgaze and downgaze palsy, 6 finally remained symptomatic. By contrast, 9 patients with upgaze palsy and 3 with downgaze palsy recovered fully within 3 months and remained free of ocular symptoms thereafter. Another clinical characteristic feature shared by these 6 patients was the involvement of the rostral midbrain as elucidated by diffusion-weighted imaging. Specifically, the paramedian tegmentum of the rostral midbrain, which is considered an area responsible for coordinating vertical eye movements, was invariably involved in all 6 patients as a visually obvious signal hyperintensity (Fig. 2). Moon et al: J Neuro-Ophthalmol 2021; 41: 29-36 DISCUSSION Of the 12,755 patients registered in our stroke database, 342 (2.7%) were identified to have thalamic infarction, which was consistent with previous studies showing that thalamic infarction constituted 3.1%–4.4% of all infarctions (4,6). Among those with thalamic infarction, neuroophthalmologic features were observed in 40 (11.7%) patients. Oculomotor abnormalities were most frequently associated with infarctions in the territory of the paramedian artery, and the most common feature was vertical gaze palsy. The frontofugal dorsothalamic bundle transverses the mediodorsal nucleus and internal medullary lamina of the thalamus, and then, it reaches the superior colliculus. The development of vertical gaze palsy can be attributed to a lesion involving this bundle (4,17). Lesions involving the 31 Copyright © North American Neuro-Ophthalmology Society. Unauthorized reproduction of this article is prohibited. Original Contribution FIG. 1. This flow diagram shows the disposition of patients with ischemic stroke according to the affected vascular territory within the thalamus. rostral interstitial nucleus of the medial longitudinal fasciculus and posterior commissure in the rostral midbrain can also lead to the development of vertical gaze palsy (17–19). In our study, 19 (67.9%) patients with paramedian infarction showed vertical gaze palsy, and 6 of them did not have any lesions in the midbrain on MRI. A previous study reported that unilateral thalamic infarction mainly causes upgaze palsy and bilateral infarction causes upgaze, downgaze, or combined vertical gaze palsy (12,20). In our study, however, 6 of the 21 patients with unilateral paramedian infarction showed combined upgaze and downgaze palsy, and only 1 of the 7 patients with bilateral paramedian infarction showed combined upgaze and downgaze palsy. Thus, unilaterality or bilaterality did not seem to affect the extent and range of vertical gaze palsy in this study. Skew deviation can occur with lesions anywhere in the vestibulo-ocular pathway, which is also believed to traverse the thalamus. As with several previous studies, skew deviation was found in this study in more than half of the patients with paramedian thalamic infarction (21,22). All of these skew deviations were associated with hypotropia of the contralateral eye, contraversive conjugate ocular torsion, and head tilt in the direction contralateral to the side of the thalamic lesion as a typical presentation of contralateral ocular tilt reaction. Pseudoabducens palsy, which is known as thalamic esotropia, is a tonic inward ocular deviation (23). The prefrontal descending cortico-oculomotor pathway for binocular convergence passes through the paramedian portion of the thalamus and the mesodiencephalic junction and terminates in oculomotor complexes. This connection exists bilaterally, and contralateral premotor neurons exert an inhibitory influence on the neurons of the oculomotor nucleus. Acute disinhibition of these neurons would result in the tonic activation of the medial rectus and cause pseudo-abducens palsy (24–26). Among our 40 patients, 8 patients with paramedian infarction were identified to have pseudoabducens palsy; however, in this retrospective study, it could not be determined whether the esotropia was contralateral or ipsilateral to the side of the lesion. TABLE 2. Neuro-ophthalmologic features of thalamic infarction according to the affected vascular territory Vertical gaze palsy, no. (%) Combined upgaze and downgaze Upgaze Downgaze Skew deviation, no. (%) Ipsilateral III cranial nerve palsy, no. (%) Pseudoabducens palsy, no. (%) Gaze-evoked nystagmus, no. (%) Ipsilateral ptosis,* no. (%) Ipsilateral miosis, no. (%) Contralateral wrong-way deviation, no. (%) One-and-a-half syndrome, no. (%) Visual field defect, no. (%) Hemianopia Quadrantanopia Paramedian infarction (n = 28) Polar Infarction (n = 2) Inferolateral Infarction (n = 5) Posterior Choroidal Infarction (n = 5) 19 (67.9) 7 9 3 18 (64.3) 10 (35.7) 9 (32.1) 3 (10.7) 3 (10.7) 2 (7.1) 1 (3.6) 0 0 0 0 0 0 0 0 0 2 (100.0) 0 0 0 0 0 1 (20.0) 0 1 (20.0) 0 0 0 0 3 (60.0) 2 1 0 0 0 0 0 0 0 1 (20.0) 4 (80.0) 1 3 *Not associated with III cranial nerve palsy. 32 Moon et al: J Neuro-Ophthalmol 2021; 41: 29-36 Copyright © North American Neuro-Ophthalmology Society. Unauthorized reproduction of this article is prohibited. Original Contribution TABLE 3. Neuro-ophthalmologic features in patients with isolated thalamic infarction Paramedian Infarction (n = 7) Polar Infarction (n = 1) 6 (85.7) 0 4 2 4 (57.1) 0 5 (62.5) 0 1 (12.5) 1 (12.5) 0 0 0 0 Vertical gaze palsy, no. (%) Combined upgaze and downgaze Upgaze Downgaze Contralateral skew deviation, no. (%) Ipsilateral III cranial nerve palsy, no. (%) Pseudoabducens palsy, no. (%) Gaze-evoked nystagmus, no. (%) Ipsilateral ptosis,* no. (%) Ipsilateral miosis, no. (%) Contralateral wrong-way deviation, no. (%) One-and-a-half syndrome, no. (%) Visual field defect, no. (%) Hemianopia Quadrantanopia 0 0 0 0 1 (100.0) 0 0 0 0 *Not associated with III cranial nerve palsy. Gaze-evoked nystagmus was detected in 4 patients. Three of them presented with a typical horizontal gazeevoked nystagmus occurring in lateral gazes, suggestive of a defective gaze-holding mechanism. The 3 patients were found to have lesions in the cerebellum as well as the thalamus. The remaining one male patient showed a gazeevoked nystagmus in vertical gaze. He also showed vertical gaze palsy, ocular tilt reaction, and vertical-torsional nystagmus in primary gaze. His brain MRI revealed a bilateral paramedian thalamic infarction. The direction of his ocular tilt reaction and torsional nystagmus was contralateral to the more severe side of the bilateral lesion. All of these findings suggested that the combined lesion involving both the rostral interstitial nucleus of the medial longitudinal fasciculus and the interstitial nucleus of Cajal was the underlying cause of his ocular motility abnormality (27–29). In our study, isolated ipsilateral ptosis without ophthalmoplegia was observed in 3 patients with paramedian infarction and 2 patients with polar infarction. TABLE 4. Detailed clinical characteristics of 6 patients with permanent oculomotor deficits Patient 1 Sex Age (yr) Risk factors TOAST classification Laterality Topographic lesion Other infarct lesions Oculomotor deficits Patient 2 Patient 3 M 53.2 DM, HTN, HL, CHD CE F 31.5 CHD F 61.8 HTN, Afib CE CE Unilateral Paramedian artery Midbrain Bilateral Paramedian artery Midbrain Unilateral Paramedian artery Midbrain, cerebellum Vertical gaze palsy, skew deviation Vertical gaze palsy, skew deviation, 3rd nerve palsy Vertical gaze palsy, skew deviation, 3rd nerve palsy, gazeevoked nystagmus Patient 4 Patient 5 Patient 6 F 47.2 Valve disease, Afib CE M 31.3 Hyperchole sterolemia LAA M 64.3 Afib Unilateral Paramedian artery Midbrain, cerebellum, temporal lobe Vertical gaze palsy, skew deviation, 3rd nerve palsy Unilateral Paramedian artery Midbrain, cerebellum Bilateral Paramedian artery Midbrain Vertical gaze palsy, skew deviation Vertical gaze palsy, skew deviation, gazeevoked nystagmus CE Afib, atrial fibrillation, CE, cardioembolism, CHD, congenital heart disease, DM, diabetes mellitus, F, female, HTN, hypertension, HL, hypercholesterolemia, LAA, large-artery atherosclerosis, M, male, TOAST, Trial of Org 10,172 in Acute Stroke Treatment. Moon et al: J Neuro-Ophthalmol 2021; 41: 29-36 33 Copyright © North American Neuro-Ophthalmology Society. Unauthorized reproduction of this article is prohibited. Original Contribution FIG. 2. Diffusion-weighted MRI scans of 6 patients with persistent oculomotor deficits. The axial view of the rostral midbrain at the same level delineates the extent of hyperintense lesion in each patient, uniformly involving the paramedian tegmentum of the rostral midbrain (white arrows). All of them had unilateral thalamic infarctions and unilateral mild ptosis. Ipsilateral ptosis has already been reported in patients with thalamic infarction, and some plausible mechanisms for the development of this ptosis without ophthalmoplegia have been proposed (30,31). First, Horner syndrome, in either complete or incomplete form, can be considered as a cause of ptosis in this clinical situation. Horner syndrome can occur from anterior thalamic lesion, which is explained by the anatomical proximity between the anterior thalamus and the hypothalamus. Furthermore, the paramedian and polar arteries supply not only the anterior thalamus but also the hypothalamus from which the sympathicoexcitatory tract originates (31,32). In this study, one patient with paramedian infarction showed ipsilateral ptosis and miosis. Although there is uncertainty on whether or not the ptosis was associated with ipsilateral anhidrosis and although pharmacologic tests could not be performed, it seemed reasonable to assume that Horner syndrome was the most likely diagnosis, considering that the infarction involved the hypothalamus and the signs suggesting third nerve palsy were absent. Second, lesions in the thal34 amus can cause “cerebral ptosis” (31,33). Several studies have reported that the internal medullary lamina, which is a strip of white matter in the thalamus, is connected to the frontal eye fields, supplementary eye fields, and posterior parietal cortex (34,35). Thus, lesions involving this connection can induce cerebral ptosis. Cerebral ptosis was reported to be unilateral or bilateral; if bilateral, it may be either symmetric or asymmetric (36). Among our subjects, 4 patients were suspected to have cerebral ptosis, all of whom had no associated pupillary miosis or ophthalmoplegia. Wrong-way deviation, a conjugate eye deviation directed contralaterally to the affected side, was identified in 1 patient with paramedian infarction. This deviation is known to be associated with supratentorial hemorrhagic or extensive ischemic stroke (37,38). In our patient, the lesion in the thalamus was rather small, whereas the associated infarction of middle cerebral artery territory was shown to be extensive in diffusion-weighted MRI. Thus, it was considered that the wrong-way deviation in our patient was more likely due to the large hemispheric infarction than the thalamic infarction itself. Moon et al: J Neuro-Ophthalmol 2021; 41: 29-36 Copyright © North American Neuro-Ophthalmology Society. Unauthorized reproduction of this article is prohibited. Original Contribution Although the oculomotor abnormalities improved early in the course of the disease, it was consistently found that if the abnormalities did not spontaneously resolve within 3 months, they remained stable for longer than 1 year. Therefore, it would be reasonable to suggest that if the oculomotor abnormalities in patients with thalamic infarction persist for more than 3 months, it is likely to become a permanent deficit without further improvement. In addition, it would also be sensible to suggest, based on the findings of this study, that the same outcome can be expected when combined upgaze and downgaze palsy is observed at the initial presentation and when the paramedian rostral midbrain is obviously affected. Visual field defects were observed in 7 patients in this study. All the 7 patients, except 1, had thalamic and extrathalamic lesions, with the latter being responsible for the visual field defects. The only 1 patient with posterior choroidal infarction and no apparent extrathalamic lesion presented with homonymous sectoral quadrantanopia in the contralateral inferior visual fields. This defect was considered to be induced by a lesion involving the lateral geniculate body, which was consistent with other previous reports (39). Hence, considering the significant number of patients without visual field defects from our data, it can be inferred that visual field defects are not commonly encountered in patients with thalamic infarction, even in those with posterior choroidal infarction. This study has several limitations that need to be acknowledged. One of the major limitations is its retrospective nature and the incomplete documentation, especially of detailed clinical outcomes after the infarction. Another limitation is related to the fact that visual fields were not always measured using Humphrey automated perimetry, but rather tested by a confrontation method in some of our subjects. Despite these limitations, this study has several noteworthy strengths. First, we used a well-established stroke database with a highly standardized and structured patient assessment protocol, which provided comprehensive data from a homogenous clinical setting over a long period of time. Second, this study included a substantial number of patients. In combination with a long-term study period, the large study population made it possible to explore the incidence, clinical features, and outcomes of neuroophthalmologic manifestations. Finally, to the best of our knowledge, this is the first study to investigate the prognostic factors of persistent oculomotor deficits in patients with thalamic infarction. In conclusion, thalamic infarction can show multiple and various neuro-ophthalmologic manifestations. The most frequent neuro-ophthalmologic finding was vertical gaze palsy, followed by skew deviation. Paramedian infarction was the most common type of infarction Moon et al: J Neuro-Ophthalmol 2021; 41: 29-36 causing oculomotor abnormalities. Although in most cases the abnormalities resolve spontaneously within a few months, in some cases, persistence of deficits was noted when the oculomotor abnormalities remained unimproved for more than 3 months. STATEMENT OF AUTHORSHIP Category 1: a. Conception and design: H. T. Lim; b. Acquisition of data: Y. Moon, K. S. Eah, E.-J. Lee, D.-W. Kang, S. U. Kwon, and J. S. Kim; c. Analysis and interpretation of data: Y. Moon and H. T. Lim; Category 2: a. Drafting the manuscript: Y. Moon and H. T. Lim; b. Revising it for intellectual content; E.-J. Lee, D.-W. Kang, S. U. Kwon, and J. S. Kim; Category 3: a. Final approval of the completed manuscript: H. T. Lim. ACKNOWLEDGMENT This research was supported by a grant of the Korea Health Technology R & D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (grant number: HI18C2383). REFERENCES 1. Schmahmann JD. Vascular syndromes of the thalamus. Stroke. 2003;34:2264–2278. 2. Castaigne P, Lhermitte F, Buge A, Escourolle R, Hauw JJ, LyonCaen O. Paramedian thalamic and midbrain infarct: clinical and neuropathological study. Ann Neurol. 1981;10:127–148. 3. Graff-Radford NR, Damasio H, Yamada T, Eslinger PJ, Damasio AR. Nonhaemorrhagic thalamic infarction: clinical, neuropsychological and electrophysiological findings in four anatomical groups defined by computerized tomography. Brain. 1985;108(pt 2):485–516. 4. Bogousslavsky J, Regli F, Uske A. Thalamic infarcts: clinical syndromes, etiology, and prognosis. Neurology. 1988;38:837–848. 5. Caplan LR, DeWitt LD, Pessin MS, Gorelick PB, Adelman LS. Lateral thalamic infarcts. Arch Neurol. 1988;45:959–964. 6. Saez de Ocariz MM, Nader JA, Santos JA, Bautista M. Thalamic vascular lesions: risk factors and clinical course for infarcts and hemorrhages. Stroke. 1996;27:1530–1536. 7. Renard D, Castelnovo G, Campello C, Bouly S, Le Floch A, Thouvenot E, Waconge A, Taieb G. Thalamic lesions: a radiological review. Behav Neurol. 2014;2014:154631. 8. Steinke W, Sacco RL, Mohr JP, Foulkes MA, Tatemichi TK, Wolf PA, Price TR, Hier DB. Thalamic stroke: presentation and prognosis of infarcts and hemorrhages. Arch Neurol. 1992;49:703–710. 9. Kumral E, Deveci EE, Colak AY, Caginda AD, Erdogan C. Multiple variant type thalamic infarcts: pure and combined types. Acta Neurol Scand. 2015;131:102–110. 10. Kumral E, Evyapan D, Balkir K, Kutluhan S. Bilateral thalamic infarction. Clinical, etiological and MRI correlates. Acta Neurol Scand. 2001;103:35–42. 11. Lin G, Zhang X, Hu B, Zou M, Chen S, Gong Y, Cheng B, He Z. Paramedian thalamic ischemic infarction: a retrospective clinical observation. Eur Neurol. 2017;77:197–200. 12. Kumral E, Evyapan D, Kutluhan S. Pure thalamic infarctions: clinical findings. J Stroke Cerebrovasc Dis. 2000;9:287–297. 13. Kim EJ, Kim MO, Kim CH, Joa KL, Jung HY. Abnormal ocular movement with executive dysfunction and personality change in subject with thalamic infarction: a case report. Ann Rehabil Med. 2015;39:1033–1037. 35 Copyright © North American Neuro-Ophthalmology Society. Unauthorized reproduction of this article is prohibited. Original Contribution 14. Lee HY, Kim MJ, Kim BR, Koh SE, Lee IS, Lee J. Acute pseudobulbar palsy after bilateral paramedian thalamic infarction: a case report. Ann Rehabil Med. 2016;40:751–756. i c D, Ozreti c D, Brinar VV, 15. Adamec I, Barun B, Mahovi c Lakus Habek M. Neuro-ophthalmologic manifestations of thalamic stroke. Neuroophthalmol. 2011;35:121–124. 16. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35–41. 17. Gentilini M, De Renzi E, Crisi G. Bilateral paramedian thalamic artery infarcts: report of eight cases. J Neurol Neurosurg Psychiatry. 1987;50:900–909. 18. Menon A, Sreedhar A, Anilkumar D, Ittyerah TP. Parinaud’s syndrome in a patient with thalamic infarction due to cerebral venous thrombosis. Indian J Ophthalmol. 2007;55:237–238. 19. Meissner I, Sapir S, Kokmen E, Stein SD. The paramedian diencephalic syndrome: a dynamic phenomenon. Stroke. 1987;18:380–385. 20. Elinor E, Rowe FJ. Ocular motility consequences following lesions of the thalamus: a literature review. Br Ir Orthopt J. 2009;6:40–46. 21. Blitshteyn S, Hentschel K, Czervionke LF, Eidelman BH. Transient vertical diplopia and nystagmus associated with acute thalamic infarction. Clin Imaging. 2006;30:54–56. 22. Brandt T, Dieterich M. Vestibular syndromes in the roll plane: topographic diagnosis from brainstem to cortex. Ann Neurol. 1994;36:337–347. 23. Fisher CM. The pathologic and clinical aspects of thalamic hemorrhage. Trans Am Neurol Assoc. 1959;84:56–59. 24. Leichnetz GR. The prefrontal cortico-oculomotor trajectories in the monkey. J Neurol Sci. 1981;49:387–396. 25. Lindner K, Hitzenberger P, Drlicek M, Grisold W. Dissociated unilateral convergence paralysis in a patient with thalamotectal haemorrhage. J Neurol Neurosurg Psychiatry. 1992;55:731–733. 26. Choi KD, Jung DS, Kim JS. Specificity of “peering at the tip of the nose” for a diagnosis of thalamic hemorrhage. Arch Neurol. 2004;61:417–422. 27. Suzuki Y, Buttner-Ennever JA, Straumann D, Hepp K, Hess BJ, Henn V. Deficits in torsional and vertical rapid eye movements and shift of Listing’s plane after uni- and bilateral lesions of the 36 28. 29. 30. 31. 32. 33. 34. 35. 36. 37. 38. 39. rostral interstitial nucleus of the medial longitudinal fasciculus. Exp Brain Res. 1995;106:215–232. Helmchen C, Glasauer S, Bartl K, Buttner U. Contralesionally beating torsional nystagmus in a unilateral rostral midbrain lesion. Neurology. 1996;47:482–486. Oh SY, Choi KD, Shin BS, Seo MW, Kim YH, Kim JS. Paroxysmal ocular tilt reactions after mesodiencephalic lesions: report of two cases and review of the literature. J Neurol Sci. 2009;277:98–102. Azabou E, Derex L, Honnorat J, Nighoghossian N, Trouillas P. Ipsilateral ptosis as main feature of tuberothalamic artery infarction. Neurol Sci. 2009;30:69–70. Kim EJ, Lee DK, Kang DH, Ku BD, Kim JS, Na DL, Lee JH. Ipsilateral ptosis associated with anterior thalamic infarction. Cerebrovasc Dis. 2005;20:410–411. Ebert AD, Vinz B, Gortler M, Wallesch CW, Herrmann M. Is there a syndrome of tuberothalamic artery infarction? A case report and critical review. J Clin Exp Neuropsychol. 1999;21:397–411. Topcular B, Yandim-Kuscu D, Colak M, Behrem N, KaragozSakalli N, Gul G, Sutlas NP, Kirbas D. Unilateral ptosis associated with paramedian thalamiic infarction. Ideggyogy Sz. 2011;64:275–276. Barbas H, Mesulam MM. Cortical afferent input to the principalis region of the rhesus monkey. Neuroscience. 1985;15:619–637. Kaufman EF, Rosenquist AC. Afferent connections of the thalamic intralaminar nuclei in the cat. Brain Res. 1985;335:281–296. Averbuch-Heller L, Leigh RJ, Mermelstein V, Zagalsky L, Streifler JY. Ptosis in patients with hemispheric strokes. Neurology. 2002;58:620–624. Pessin MS, Adelman LS, Prager RJ, Lathi ES, Lange DJ. “Wrong-way eyes” in supratentorial hemorrhage. Ann Neurol. 1981;9:79–81. Johkura K, Nakae Y, Yamamoto R, Mitomi M, Kudo Y. Wrong-way deviation: contralateral conjugate eye deviation in acute supratentorial stroke. J Neurol Sci. 2011;308:165–167. Neau JP, Bogousslavsky J. The syndrome of posterior choroidal artery territory infarction. Ann Neurol. 1996;39:779–788. Moon et al: J Neuro-Ophthalmol 2021; 41: 29-36 Copyright © North American Neuro-Ophthalmology Society. Unauthorized reproduction of this article is prohibited.